Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
HNF4A and SREBF1 hepatocyte nuclear factor 4, alpha sterol regulatory element binding transcription factor 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • RORA activates circadian gene expression
HNF4A and SREBF2 hepatocyte nuclear factor 4, alpha sterol regulatory element binding transcription factor 2
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Transcriptional regulation of white adipocyte differentiation
  • Activation of gene expression by SREBF (SREBP)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
HNF4A and MED14 hepatocyte nuclear factor 4, alpha mediator complex subunit 14
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
HNF4A and PPARGC1A hepatocyte nuclear factor 4, alpha peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Organelle biogenesis and maintenance
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • REV-ERBA represses gene expression
  • RORA activates circadian gene expression
  • Mitochondrial biogenesis
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
HNF4A and MED21 hepatocyte nuclear factor 4, alpha mediator complex subunit 21
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
HNF4A and NCOA1 hepatocyte nuclear factor 4, alpha nuclear receptor coactivator 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Bile acid and bile salt metabolism
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Metabolism of lipids and lipoproteins
  • Metabolic disorders of biological oxidation enzymes
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Generic Transcription Pathway
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Cytochrome P450 - arranged by substrate type
  • Endogenous sterols
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
HNF4A and NRIP1 hepatocyte nuclear factor 4, alpha nuclear receptor interacting protein 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and SUMO2 hepatocyte nuclear factor 4, alpha small ubiquitin-like modifier 2
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • SUMO is proteolytically processed
  • Post-translational protein modification
  • SUMOylation
  • SUMO is conjugated to E1 (UBA2:SAE1)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • Processing and activation of SUMO
HNF4A and PRMT1 hepatocyte nuclear factor 4, alpha protein arginine methyltransferase 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Chromatin modifying enzymes
  • Chromatin organization
  • RMTs methylate histone arginines
HNF4A and PROX1 hepatocyte nuclear factor 4, alpha prospero homeobox 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and NPPA hepatocyte nuclear factor 4, alpha natriuretic peptide A
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Amyloids
  • Generic Transcription Pathway
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
HNF4A and NCOA6 hepatocyte nuclear factor 4, alpha nuclear receptor coactivator 6
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Organelle biogenesis and maintenance
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • REV-ERBA represses gene expression
  • RORA activates circadian gene expression
  • Mitochondrial biogenesis
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Activation of gene expression by SREBF (SREBP)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Orphan transporters
HNF4A and PNRC2 hepatocyte nuclear factor 4, alpha proline-rich nuclear receptor coactivator 2
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and XPO1 hepatocyte nuclear factor 4, alpha exportin 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Loss of Function of TGFBR2 in Cancer
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • TGF-beta receptor signaling activates SMADs
  • Influenza Life Cycle
  • Export of Viral Ribonucleoproteins from Nucleus
  • RNF mutants show enhanced WNT signaling and proliferation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Host Interactions of HIV factors
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Influenza Infection
  • Late Phase of HIV Life Cycle
  • Resolution of Sister Chromatid Cohesion
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • HIV Infection
  • Rev-mediated nuclear export of HIV RNA
  • G2/M Transition
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • HuR stabilizes mRNA
  • deactivation of the beta-catenin transactivating complex
  • M Phase
  • HIV Life Cycle
  • Rev-mediated nuclear export of HIV RNA
  • Cyclin A/B1 associated events during G2/M transition
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Interactions of Rev with host cellular proteins
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • TCF dependent signaling in response to WNT
  • Signaling by WNT in cancer
  • SMAD4 MH2 Domain Mutants in Cancer
HNF4A and MAPK3 hepatocyte nuclear factor 4, alpha mitogen-activated protein kinase 3
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Signaling by FGFR in disease
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Cellular Senescence
  • ERKs are inactivated
  • Signaling by EGFRvIII in Cancer
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • SHC-mediated signalling
  • Regulation of actin dynamics for phagocytic cup formation
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • Senescence-Associated Secretory Phenotype (SASP)
  • ERK1 activation
  • Signaling by VEGF
  • Downstream signal transduction
  • Toll Like Receptor 3 (TLR3) Cascade
  • Signalling to RAS
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Frs2-mediated activation
  • Axon guidance
  • IRS-mediated signalling
  • L1CAM interactions
  • Oncogene Induced Senescence
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Signaling by Insulin receptor
  • ERKs are inactivated
  • Signal transduction by L1
  • Insulin receptor signalling cascade
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • Signaling by FGFR
  • Thrombin signalling through proteinase activated receptors (PARs)
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signal attenuation
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • ERK/MAPK targets
  • MAPK targets/ Nuclear events mediated by MAP kinases
  • Signaling by GPCR
  • FCERI mediated MAPK activation
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Toll Like Receptor 9 (TLR9) Cascade
  • ERK/MAPK targets
  • Negative regulation of FGFR signaling
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Growth hormone receptor signaling
  • Signaling by Leptin
  • Signalling to ERKs
  • Prolonged ERK activation events
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • RNA Polymerase I Promoter Clearance
  • IGF1R signaling cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • IRS-related events triggered by IGF1R
  • Activation of the AP-1 family of transcription factors
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • Downstream signaling of activated FGFR
  • Advanced glycosylation endproduct receptor signaling
  • Signalling by NGF
  • SOS-mediated signalling
  • MAP kinase activation in TLR cascade
  • RNA Polymerase I Transcription
  • SHC-mediated signalling
  • Cytokine Signaling in Immune system
  • Cellular response to heat stress
  • Regulation of HSF1-mediated heat shock response
  • NGF signalling via TRKA from the plasma membrane
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • SHC1 events in EGFR signaling
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Oxidative Stress Induced Senescence
  • RNA Polymerase I Promoter Opening
  • Nuclear Events (kinase and transcription factor activation)
  • Sulindac
  • Arsenic trioxide
  • Purvalanol
  • 5-iodotubercidin
HNF4A and MED1 hepatocyte nuclear factor 4, alpha mediator complex subunit 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Organelle biogenesis and maintenance
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Nuclear Receptor transcription pathway
  • REV-ERBA represses gene expression
  • RORA activates circadian gene expression
  • Mitochondrial biogenesis
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Orphan transporters
HNF4A and TAF6 hepatocyte nuclear factor 4, alpha TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • HIV Infection
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • HIV Life Cycle
  • HIV Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase II HIV Promoter Escape
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
HNF4A and MED17 hepatocyte nuclear factor 4, alpha mediator complex subunit 17
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
HNF4A and PNRC1 hepatocyte nuclear factor 4, alpha proline-rich nuclear receptor coactivator 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and MED7 hepatocyte nuclear factor 4, alpha mediator complex subunit 7
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)

Page 19 out of 155 pages